In 2018 an international standard for Multiple Sclerosis (MS) care was defined (Fig. 1) (
![Fig 1]()
Hobart and Bowen, 2019
). MS Brain Health sets the goal for a diagnostic work up within four weeks of referral
and treatment with disease-modifying therapy (DMT) initiated within another four weeks.
Clinical follow-up is recommended every six months, which includes annual radiological
review (
- Hobart J.
- Bowen A.
- Pepper G.
- Crofts H.
- Eberhard L.
- Berger T.
- Boyko A.
- Boz C.
- Butzkueven H.
- Celius E.G.
- Drulovic J.
- Flores J.
- Horáková D.
- Lebrun-Frénay C.
- Marrie R.A.
- Overell J.
- Piehl F.
- Rasmussen P.V.
- Sá M.J.
- Sîrbu C.A.
- Skromne E.
- Torkildsen Ø.
- van Pesch V.
- Vollmer T.
- Zakaria M.
- Ziemssen T.
- Giovannoni G.
International consensus on quality standards for brain health-focused care in multiple
sclerosis.
Mult. Scler. 2019; 25 (Epub 2018 Nov 1. PMID: 30381987; PMCID: PMC6826858): 1809-1818https://doi.org/10.1177/1352458518809326
Hobart and Bowen, 2019
). MS Brain Health is endorsed internationally by organisations specialising in the
clinical and research care of people with MS, as well as MS patient advocacy organisations.
- Hobart J.
- Bowen A.
- Pepper G.
- Crofts H.
- Eberhard L.
- Berger T.
- Boyko A.
- Boz C.
- Butzkueven H.
- Celius E.G.
- Drulovic J.
- Flores J.
- Horáková D.
- Lebrun-Frénay C.
- Marrie R.A.
- Overell J.
- Piehl F.
- Rasmussen P.V.
- Sá M.J.
- Sîrbu C.A.
- Skromne E.
- Torkildsen Ø.
- van Pesch V.
- Vollmer T.
- Zakaria M.
- Ziemssen T.
- Giovannoni G.
International consensus on quality standards for brain health-focused care in multiple
sclerosis.
Mult. Scler. 2019; 25 (Epub 2018 Nov 1. PMID: 30381987; PMCID: PMC6826858): 1809-1818https://doi.org/10.1177/1352458518809326

Fig. 1Good standard of care for people with MS (Hobert et al., 2018).
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Multiple Sclerosis and Related DisordersAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- International consensus on quality standards for brain health-focused care in multiple sclerosis.Mult. Scler. 2019; 25 (Epub 2018 Nov 1. PMID: 30381987; PMCID: PMC6826858): 1809-1818https://doi.org/10.1177/1352458518809326
- Health outcomes and access to health and hospital services in rural, regional and remote New South Wales. 2022; (May 5) (Parliament of NSW)
- Location: Census. 2021; (Retrieved from Australian Bureau of Statistics)
Australian Government, Department of health and aged care. (15 March 2023). https://www.health.gov.au/topics/rural-health-workforce/how-we-support#policy-and-strategy.
- How do we fix the shortage of neurologists?.Lancet Neurol. 2018; 17: 502-503https://doi.org/10.1016/s1474-4422(18)30143-1
- Disparities in telehealth care in multiple sclerosis.Neurol. Clin. Pract. 2022; 12 (PMID: 35747551; PMCID: PMC9208413): 223-233https://doi.org/10.1212/CPJ.0000000000001167
- RADAR-CNS. Experiences of health tracking in mobile apps for multiple sclerosis: a qualitative content analysis of user reviews.Mult. Scler. Relat. Disord. 2023; 69 (Epub 2022 Nov 28. PMID: 36493561)104435https://doi.org/10.1016/j.msard.2022.104435
- Health disparities, inequities, and social determinants of health in multiple sclerosis and related disorders in the US: a review.JAMA Neurol. 2021; 78 (PMID: 34605866): 1515-1524https://doi.org/10.1001/jamaneurol.2021.3416
- Social determinants of health in multiple sclerosis.Nat. Rev. Neurol. 2022; 18 (Epub 2022 Nov 11. PMID: 36369488; PMCID: PMC9651126): 723-734https://doi.org/10.1038/s41582-022-00735-5
- Inequalities in access to health and social care among adults with multiple sclerosis: a scoping review of the literature.Mult. Scler. Relat. Disord. 2019; 28 (Epub 2019 Jan 3. PMID: 30641354): 290-304https://doi.org/10.1016/j.msard.2018.12.043
- Barriers to the accessibility and continuity of health-care services in people with multiple sclerosis: a literature review.Int. J. MS Care. 2017; 19: 313-321https://doi.org/10.7224/1537-2073.2016-016
- Access to and utilization of neurologists by people with multiple sclerosis.Neurology. 2008; 70 (13 Pt 2PMID: 18362274): 1141-1149https://doi.org/10.1212/01.wnl.0000306411.46934.ef
- Reduced cognitive function contributes to economic burden of multiple sclerosis.Mult. Scler. Relat. Disord. 2022; 60 (Epub 2022 Feb 22. PMID: 35235899)103707https://doi.org/10.1016/j.msard.2022.103707
- Multiple sclerosis in Canada 2011 to 2031: results of a microsimulation modelling study of epidemiological and economic impacts.Health Promot. Chronic Dis. Prev. Can. 2017; 37 (PMID: 28273039; PMCID: PMC5607528): 37-48https://doi.org/10.24095/hpcdp.37.2.02
- Economic burden of the out-of-pocket expenses for people with multiple sclerosis in France.Pharmacoecon. Open. 2020; 4 (PMID: 32043229; PMCID: PMC7688762): 593-603https://doi.org/10.1007/s41669-020-00199-7
- The economic burden of multiple sclerosis in the United States: estimate of direct and indirect costs.Neurology. 2022; 98 (Epub 2022 Apr 13. PMID: 35418457; PMCID: PMC9109149): e1810-e1817https://doi.org/10.1212/WNL.0000000000200150
Editorial, 2023 Lancet Neurology, Volume 22, Issue 3:189. doi:10.1016/S1474-4422(23)00041-8.
Article info
Publication history
Published online: March 22, 2023
Identification
Copyright
Crown Copyright © 2023 Published by Elsevier B.V. All rights reserved.